MarketPeel
Insider Trading Intelligence
Pricing
…
BD

Behrad Derakhshan

EWTX
CHIEF BUSINESS OFFICER · EDGEWISE THERAPEUTICS, INC. · CIK 0001853109
FILING MIX · LIFETIME47%/53%
BUYS
21
SELLS
24
TOTAL VALUE
$2.17M
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
11,563
AVG SELL PX
$27.46
TRADE KIND
SHOWING 45 / 45
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Behrad Derakhshan, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+66.67%-5.09%+0.34%-5.44%-8.31%—
14d9+66.67%-5.45%+1.67%-7.12%-12.19%—
30d9+66.67%-2.83%+2.16%-5.00%-15.62%—
60d9+66.67%-13.18%+3.07%-16.25%-19.73%—
90d9+44.44%-4.03%+5.23%-9.26%-1.39%—
180d9+77.78%+5.96%+7.34%-1.38%-23.83%—
1y9+33.33%+52.23%+20.12%+32.11%+14.04%—
2y9(4 pending)+0.00%+59.46%+41.29%+18.17%+14.17%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EWTX · 11,563 shares · as of Aug 12, 2026
055,000110,000165,000220,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 21 buys / 24 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000——100,000Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
7,500——36,926Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
304$44.50$13.5K34,451Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
5,781——29,426Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,000——50,000Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
7,500——22,500Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
5,781——11,563Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
150$44.44$6.7K34,301Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
2,475$43.70$108.2K31,826Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
2,171$43.79$95.1K34,755Aug 12, 2026Aug 13, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,000——30,000Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
180,000——180,000Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
2,491$13.39$33.4K23,645Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
5,781——17,344Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
5,781——26,136Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
1,691$16.45$27.8K20,355May 2, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
5,209——22,046May 1, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
5,209——0May 1, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
10,000——92,929Feb 5, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
10,000$1.93$19.3K26,837Feb 5, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
10,000$30.03$300.3K16,837Feb 5, 2025Feb 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
42,068——102,949Sep 20, 2024Sep 24, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
42,068$1.93$81.2K57,189Sep 20, 2024Sep 24, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
42,068$29.03$1.22M15,121Sep 20, 2024Sep 24, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
138,750——138,750Aug 12, 2024Aug 14, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
23,125——23,125Aug 12, 2024Aug 14, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
1,718$18.91$32.5K13,422May 2, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
5,208——15,140May 1, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
5,208——5,209May 1, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
4,800$1.93$9.3K11,820Feb 9, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
4,800——145,017Feb 9, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
4,800$20.04$96.2K7,020Feb 9, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
4,600$1.93$8.9K11,620Feb 8, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,600$20.01$92.0K7,020Feb 8, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
4,600——149,817Feb 8, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
600$1.93$1.2K7,620Feb 7, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
600$20.00$12.0K7,020Feb 7, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
600——154,417Feb 7, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
220,000——220,000Aug 17, 2023Aug 18, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
1,747$8.90$15.6K7,020May 2, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
5,208——8,767May 1, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
Chief Business Officer
5,208——10,417May 1, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Aug 8, 2022Aug 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,625——15,625May 1, 2022May 3, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
140,000——140,000Aug 17, 2021Aug 19, 2021 ↗View →
Other insiders · EWTX
Loading peer insiders…
About this filer
CIK 0001853109
ROLE
Chief Business Officer
PRIMARY
EWTX
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001853109DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback